Key terms

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ACRS news

Yesterday 4:37pm ET Aclaris Therapeutics Corporate Update Conference Call by TipRanks Mar 19 4:43pm ET Board Changes Ahead of Aclaris Therapeutics Annual Meeting by TipRanks Mar 01 1:08am ET Aclaris Therapeutics: Hold Rating Amidst Strategic Review and Clinical Setbacks by TipRanks Feb 27 7:07am ET Aclaris Therapeutics reports Q4 EPS (2c), consensus (34c) by TipRanks

No recent press releases are available for ACRS

ACRS Financials

1-year income & revenue

Key terms

ACRS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ACRS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Close-up detail of the Disney+ app icon on an Apple iPhone 12 Pro smartphone screen, on November 11, 2020. (Photo by Phil Barker/Future Publishing via Getty Images)
Phil Barker/Future Publishing/Getty Images
Disney just had its worst day in a year and a half
People shop in a supermarket in the Manhattan borough of New York city on January 27, 2024. (Photo by Charly TRIBALLEAU / AFP) (Photo by CHARLY TRIBALLEAU/AFP via Getty Images)
Charly Triballeau/AFP/Getty Images
Americans have spent their savings. Economists worry about what comes next
Berkshire Hathaway Chairman Warren Buffett walks through the exhibit hall as shareholders gather to hear from the billionaire investor at Berkshire Hathaway Inc's annual shareholder meeting in Omaha, Nebraska, on May 4, 2019.
Scott Morgan/Reuters/File
Warren Buffett compares AI to nuclear weapons in stark warning
The US Securities and Exchange Commission (SEC) headquarters in Washington, DC, US, on Wednesday, Jan. 10, 2024. The SEC's X account was compromised and a fake post claiming that the agency had green lit plans for a spot-Bitcoin exchange-traded fund fueled a brief surge in the price of the world's biggest cryptocurrency. Photographer: Graeme Sloan/Bloomberg via Getty Images
Graeme Sloan/Bloomberg/Getty Images
Trump Media fires accounting firm after old one accused of being a ‘sham audit mill’